Skip to Main Content

SEMDA Medtech to Showcase Over 20 High-Impact New Technologies, National Speakers at May 2-4 Conference

Leading-edge innovators present for recognition, reward at annual gathering of Southeastern who’s who in medical technology, devices and diagnostics


Greenville, SC – April 27, 2018 – At least 23 organizations ranging from start-ups to well-established companies have been accepted to present their latest, ground-breaking innovations to entrepreneurs, innovators, angel investors and business leaders from across the life sciences space as the Southeastern Medical Device Association (SEMDA) 2018 Medtech Conference convenes in Greenville, SC May 2-4, 2018.  

SEMDA -- a non-profit trade association focused on making the Southeast a world-class region for medical technology, device, and diagnostic companies – has invited 23 finalist companies to present at PitchRounds 2018 – a highly targeted venue for both “Seed” companies as well as later-stage organizations to present innovative ideas to panels of institutional investors, regulatory leaders, venture capital directors, IP experts and others.

Companies from seven Southeastern states will present ground-breaking ideas and technologies to hundreds of industry leaders.  Host state South Carolina leads the way with 10 companies invited to present, followed by Georgia and Florida with three companies each.  North Carolina, Alabama, Virginia and Tennessee are also represented.

Among the South Carolina companies invited to present are Zylo Therapeutics, Accessible Diagnostics, KIYATEC and Moterum from host city Greenville, while Charleston’s Sanguine Technologies and Cryogenix, and Columbia’s Proof Biotechnologies are also invited.

Invitees from Georgia include Intent Solutions and nfant, both of Atlanta, while North Carolina entries include Diamond Othopedic of CharlotteMemphis, Tennessee’s Sweetbio, Birmingham’s Circulogene and Nashville’s Raiven are also featured invitees.

Twelve Early-stage companies from the Carolinas, Alabama and Florida have been invited to present at PitchRounds, with four finalists to be selected to compete for $10,000 in prize money, while getting to meet investors and partners at sessions and networking receptions.  SCBIO, SCRA and global law firm Eversheds Sutherland are co-sponsors of PitchRounds.

Among the featured speakers committed to present at the conference are keynoter Joe Lee, Executive Director of Life Sciences for JP Morgan; Andy Fish, Chief Strategy Officer of AdvaMed; and Denise Hines, North American Chair of the Health Information & Management Systems Society and current CEO of eHealth Services Group.   

Joe Lee is Executive Director of Life Sciences for JP Morgan and leads the Middle Market Banking coverage of life science companies across the Southeast. Widely respected in life science industry circles, Mr. Lee will discuss key opportunity areas for growth in the Southeast and provide rapid-growth companies with counsel on how to prepare their organizations for success in the competitive space.

Andrew Fish is Chief Strategy Officer of AdvaMed, the leading trade association advancing medical technology in the U.S. and around the world. As chief strategy officer, Mr. Fish leads the association’s strategic planning, oversees AdvaMed's global, regulatory, and payment departments, and coordinates the development and operations of AdvaMed’s membership divisions and sectors.

Dr. Denise Hines is current Chair of the North America Board of the Health Information & Management Systems Society (HIMSS), and is actively involved in HIMSS’ Women in Health IT initiatives that promote diversity and recognition.  She is CEO of eHealth Services Group and serves as Executive Director of Georgia’s statewide health information exchange (HIE).

“The Southeastern medtech industry as a whole shows incredible growth and promise, and the diverse entries from across the region reflect that growth,” said Jason Rupp, Executive Director of SEMDA.  “PitchRounds gives us the chance to see the future come to life before our eyes with cutting-edge innovation and game-changing advancements in medical technology, devices and diagnostics from some of America’s brightest minds.”

The SEMDA conference typically attracts more than 400 executives in medtech and life sciences from throughout the United States and has become a must-attend for the medtech community. Registration is strong but space is still available, noted Mr. Rupp.  Persons interested in attending can review the agenda, speakers and registration details online at http://www.semda.net.

“These presenters and companies demonstrate that SEMDA has evolved into a truly regional organization that embraces and represents a diverse collective of medtech startups, universities, corporate organizations, investment resources, suppliers and capabilities from across the southeastern United States,” Mr. Rupp added.

About SEMDA

The Southeastern Medical Device Association (SEMDA) is a regional non-profit trade association that supports and promotes medical device and medical device data system (MDDS) companies in the Southeast. Created in 2004, the association provides unique educational resources to accelerate device development and achieve commercial success with access to funding, education, and networking opportunities for medical device companies, inventors, physicians, investors, tech transfer offices, universities, sponsors, and service providers interested in growing the medical device industry in the Southeast.

 

 

 

Invited and scheduled to present at PitchRounds 2018

 

LATER STAGE (RAISING SERIES A OR LATER)

Company

Name

City/Town

ST

Kiyatec

Matt Gevaert

Greenville

SC

Intent Solutions

Sam Zamarippa

Atlanta

GA

Moterum

David Huizenga

Greenville

SC

Diamond Orthopedic

JD Williams

Charlotte

NC

Circulogene

Mike Mullen

Birmingham

AL

Sweetbio

Kayla Rodriguez Graff

Memphis

TN

Xhale, Inc.

Douglas Crumb

Gainesville

FL

Embody LLC

Jeffrey Conroy

Norfolk

VA

nfant

Lou Malice

Atlanta

GA

Kyndermed

Melanie Simmons

Tallahassee

FL

Raiven

Jim Stefansic

Nashville

TN

Fraudscope

Musheer Ahmed

Atlanta

GA

 

 

 

 

 EARLY STAGE

Company

Name

City/Town

ST

Zylö Therapeutics

Scott Pancoast

Greenville

SC

Sanguine Technologies Inc.

John Forrest

Charleston

SC

Accessible Diagnostics, LLC

John Warner

Greenville

SC

VitalFlo

Luke Marshall, Ph.D.

Raleigh

NC

Cryogenix, LLC

John Baatz

Charleston

SC

Aravis BioTech LLC

Jeffrey Anker

Greenville

SC

Purilogics, LLC

Jinxiang Zhou

Greenville

SC

OrthoScrews, LLC

Zoe Guckien

Tuscaloosa

AL

DiaTech Diabetes Technology

John Gray

Tallahassee

FL

Proof Biotechnologies, Inc

Chang Kang

Columbia

SC

PivotSC LLC/ XtremedX

Frank Patterson

Greenville

SC